A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.
By GINA KOLATA from NYT Health http://ift.tt/2fBCrz7
via IFTTT
Clinical Trials, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247